New combo treatment tested for rapid relief of suicidal thoughts

NCT ID NCT07396220

Summary

This study is testing whether a combination treatment works better than medication alone for quickly reducing suicidal thoughts. Researchers are comparing a nasal spray medication (esketamine) plus a brief talk therapy to the nasal spray by itself. They are enrolling adults aged 18-70 with depression and suicidal thoughts who haven't improved with prior treatments. The goal is to see if the combined approach leads to a greater reduction in suicidal thinking one week after treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDAL IDEATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • UC San Diego Health - 4S Ranch

    San Diego, California, 92127, United States

Conditions

Explore the condition pages connected to this study.